跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
cyclophosphamide cell therapy
首页
药物
cyclophosphamide cell therapy
cyclophosphamide cell therapy
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHODS OF CONDITIONING PATIENTS FOR T CELL THERAPY
EP 3302508 A4
申请人: US HEALTH
优先权: 2015
CN
EP
US
WO
14 件公开
METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASES
EP 4687962 A1
申请人: CABALETTA BIO INC
优先权: 2023
CN
EP
US
WO
4 件公开
EP 4687963 A1
申请人: CABALETTA BIO INC
优先权: 2023
EP
US
WO
3 件公开
USES OF ANTI-CD40 ANTIBODIES
US 2011002934 A1
申请人: NOVARTIS AG
优先权: 2008
CN
US
2 件公开
METHODS FOR THE TREATMENT OF B CELL MALIGNANCIES USING ADOPTIVE CELL THERAPY
US 20250197471 A1
申请人: JUNO THERAPEUTICS INC
优先权: 2016
CN
US
2 件公开
CHIMERIC ANTIGEN RECEPTOR TARGETING ONCOLYTIC VIRUS-DERIVED PROTEIN, IMMUNOCYTE EXPRESSING SAME, AND USES OF BOTH
US 20240181058 A1
申请人: BIONOXX INC
优先权: 2021
CN
US
2 件公开
Method for improving advanced refractory cervical cancer through TIL therapy
CN 111195264 A
申请人: CAR-T (SHANGHAI) CELL BIOTECHNOLOGY CO LTD
优先权: 2020
CN
Methods of promoting persistence of cell therapy
CN 119604308 A
申请人: NANJING LEGEND BIOTECH CO LTD
优先权: 2022
CN
Application of camellia oil in prevention and treatment of ovarian function decline
CN 119679872 A
申请人: UNIV JILIN
优先权: 2025
CN
药物
反馈